Tissue Sensor to Reduce the Need for Controlled Apnea During Retrograde Intrarenal Surgery (Tissue Sensor)
Retrograde intrarenal surgery is an established minimally invasive treatment for renal stones. During laser lithotripsy, respiratory motion causes the kidney, renal collecting system, and stone to move relative to the distal tip of the laser fiber. This can impair precise fiber positioning, reduce operative-field stability, and increase the risk of unintended laser exposure of the urothelium of the renal collecting system.
To reduce respiratory motion of the kidney, the surgeon may ask the anesthesiologist to temporarily pause mechanical ventilation. Controlled apnea can briefly stabilize the operative field; however, it requires interruption of ventilation and may cause oxygen desaturation, carbon dioxide accumulation, hemodynamic changes, and increased anesthetic burden.
Tissue Sensor is a technology that automatically terminates laser emission when contact between the distal tip of the laser fiber and tissue is detected. Tissue Sensor is expected to reduce the risk of unintended laser exposure of the renal collecting-system mucosa during respiratory motion of the kidney.
Greater surgeon confidence in the safety of laser activation may reduce the need to stabilize the kidney with controlled apnea. At the same time, brief automatic interruptions of laser emission may increase lithotripsy time and total operative time.
調査の概要
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Nikita Astakhov
- 電話番号:+8 (968) 490-46-72
- メール:astakhov.nikita@inbox.ru
研究連絡先のバックアップ
- 名前:Vigen Malkhasyan, Doctor of Medical Sciences
- 電話番号:+79096441688
- メール:botkinhospital@zdrav.mos.ru
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Age 18 years or older.
- A single renal stone.
- An indication for elective RIRS.
- Feasibility of performing the intervention with a flexible ureteroscope.
- Recommended stone diameter on CT: 7-15 mm.
- Stone located in a calyx, a group of calyces, or the renal pelvis.
- Feasibility of TFL use.
- General anesthesia with controlled mechanical ventilation.
- No active urinary tract infection.
- Ability to undergo low-dose non-contrast CT at 1 month.
- Signed written informed consent.
Exclusion Criteria:
- Multiple stones in the study kidney.
- Complete or partial staghorn stone.
- Ipsilateral ureteral stone.
- Renal or upper urinary tract anomaly that substantially alters the anatomy.
- Horseshoe, pelvic, or ectopic kidney.
- Stone within a calyceal diverticulum.
- Ureteral stricture.
- Previous reconstructive surgery involving the study kidney or ureter.
- Active infection, obstructive pyelonephritis, or urosepsis.
- Nephrostomy drainage.
- Pregnancy.
- Severe respiratory failure or a contraindication to apnea.
- Severe cardiovascular instability.
- Inability to undergo general anesthesia.
- Combined, bilateral, or percutaneous intervention.
- Suspected upper urinary tract tumor.
- Inability to comply with the study protocol.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:patients with a single renal stone who are scheduled for elective retrograde intrarenal surger
RIRS will be performed using a thulium fiber laser with Tissue Sensor activated. All automatic system trigger events will be recorded and, whenever possible, synchronized with the procedure video recording. |
RIRS will be performed using the same TFL system with Tissue Sensor deactivated. Visually confirmed contacts between the activated laser fiber and the mucosa will be recorded from the procedure video. RIRS will be performed using a thulium fiber laser with Tissue Sensor activated. All automatic system trigger events will be recorded and, whenever possible, synchronized with the procedure video recording.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
|---|---|
|
Proportion of patients requiring at least one episode of controlled intraoperative apnea during laser lithotripsy.
時間枠:intraoperative
|
intraoperative
|
二次結果の測定
結果測定 |
時間枠 |
|---|---|
|
• number of apnea episodes;
時間枠:intraoperative
|
intraoperative
|
|
total apnea duration;
時間枠:intraoperative
|
intraoperative
|
|
mean number of apnea episodes per patient;
時間枠:intraoperative
|
intraoperative
|
|
maximum duration of a single apnea episode;
時間枠:intraoperative
|
intraoperative
|
|
minimum SpO2;
時間枠:intraoperative
|
intraoperative
|
|
incidence of desaturation;
時間枠:intraoperative
|
intraoperative
|
|
visible laser-induced mucosal
時間枠:intraoperative
|
intraoperative
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- MoscowBotkinHospital3
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。